Calcium channelopathies and Alzheimer's disease: Insight into therapeutic success and failures

Chakroborty, Shreaya, Stutzmann, Grace E.·2014·European Journal of Pharmacology
DOI 10.1016/j.ejphar.2013.11.012

Cites (236)

Items 201–236 of 236

  1. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: A multi-electrode array study
    Seon‐Ah Chong, Iryna Benilova, Hamdy Shaban, Bart De Strooper, Herman Devijver, Dieder Moechars, Wolfgang Eberle, Carmen Bartic, Fred VAN LEUVEN, Geert Callewaert · 2011 · Neurobiology of Disease
  2. A wide spectrum of clinical, neurophysiological and neuroradiological abnormalities in a family with a novel CACNA1A mutation
    Romina Romaniello, Claudio Zucca, A. Tonelli, S. Bonato, Cinzia Baschirotto, Nicoletta Zanotta, Roberta Epifanio, Andrea Righini, Nereo Bresolin, Maria Teresa Bassi et al. · 2010 · Journal of Neurology Neurosurgery & Psychiatry
  3. Alterations in neuronal calcium levels are associated with cognitive deficits after traumatic brain injury
    Laxmikant S. Deshpande, David A. Sun, Sompong Sombati, Anya Baranova, Margaret S. Wilson, Elisa Attkisson, Robert J. Hamm, Robert John DeLorenzo · 2008 · Neuroscience Letters
  4. Use-dependent amplification of presynaptic Ca 2+ signaling by axonal ryanodine receptors at the hippocampal mossy fiber synapse
    Hidemi Shimizu, Masahiro Fukaya, Miwako Yamasaki, Masahiko Watanabe, Toshiya Manabe, Haruyuki Kamiya · 2008 · Proceedings of the National Academy of Sciences
  5. The T‐type voltage‐gated calcium channel as a molecular target of the novel cognitive enhancer ST101: enhancement of long‐term potentiation and CaMKII autophosphorylation in rat cortical slices
    Shigeki Moriguchi, Norifumi Shioda, Yui Yamamoto, Hideaki Tagashira, Kohji Fukunaga · 2012 · Journal of Neurochemistry
  6. Up‐regulation of the type 3 ryanodine receptor is neuroprotective in the TgCRND8 mouse model of Alzheimer’s disease
    Charlene B Supnet, Charmain Noonan, Kelly Richard, John Bradley, Michael B. Mayne · 2009 · Journal of Neurochemistry
  7. Can Lithium or Valproate Untie Tangles in Alzheimer's Disease?
    Pierre N. Tariot, Paul S. S Aisen · 2009 · The Journal of Clinical Psychiatry
  8. A Novel Cognitive Enhancer, ZSET1446/ST101, Promotes Hippocampal Neurogenesis and Ameliorates Depressive Behavior in Olfactory Bulbectomized Mice
    Norifumi Shioda, Yui Yamamoto, Feng Han, Shigeki Moriguchi, Yoshimasa Yamaguchi, Masataka Hino, Kohji Fukunaga · 2010 · Journal of Pharmacology and Experimental Therapeutics
  9. Inactivation of presenilins causes pre‐synaptic impairment prior to post‐synaptic dysfunction
    Dawei Zhang, Chen Zhang, Angela Ho, Alfredo Kirkwood, Thomas Christian Südhof, Jie Shen · 2010 · Journal of Neurochemistry
  10. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets
    Pei, Jin-Jing, Sjögren, Magnus, Winblad, Bengt · 2008 · Current Opinion in Psychiatry
  11. Tau in neurodegenerative diseases: Tau phosphorylation and assembly
    Jesús Ávila, Mar Pérez, Filip Lim, Alberto Gómez‐Ramos, Félix Hernández, José J. Lucas · 2004 · Neurotoxicity Research
  12. Distinctive characteristics and functions of multiple mitochondrial Ca2+ influx mechanisms
    Shi Pan, Shin‐Young Ryu, Shey‐Shing Sheu · 2011 · Science China Life Sciences
  13. Calcium dysregulation in Parkinson’s disease
    Anthony H.V. Schapira · 2013 · Brain
  14. Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3 H)-one (ZSET1446/ST101) Treatment Rescues Olfactory Bulbectomy-Induced Memory Impairment by Activating Ca2+/Calmodulin Kinase II and Protein Kinase C in Mouse Hippocampus
    Feng Han, Norifumi Shioda, Shigeki Moriguchi, Yui Yamamoto, A. Ali Raie, Yoshimasa Yamaguchi, Masataka Hino, Kohji Fukunaga · 2008 · Journal of Pharmacology and Experimental Therapeutics
  15. A translational continuum of model systems for evaluating treatment strategies in Alzheimer’s disease: isradipine as a candidate drug
    Philip F. Copenhaver, Thimmappa S. Anekonda, Derek T. Musashe, Kristine M. Robinson, Jenna M. Ramaker, Tracy L. Swanson, Teri L. Wadsworth, Doris Kretzschmar, Randall L. Woltjer, Joseph F. Quinn · 2011 · Disease Models & Mechanisms
  16. Calcium enhances the proteolytic activity of BACE1: An in vitro biophysical and biochemical characterization of the BACE1–calcium interaction
    Michael Hayley, Samantha Perspicace, Therese Schulthess, Joachim Seelig · 2009 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  17. α-Isoform of calcium-calmodulin-dependent protein kinase II and postsynaptic density protein 95 differentially regulate synaptic expression of NR2A– and NR2B–containing N-methyl-d-aspartate receptors in hippocampus
    C.S. Park, Ype Elgersma, Seth G. N. Grant, John H. Morrison · 2007 · Neuroscience
  18. Stabilizers of Neuronal and Mitochondrial Calcium Cycling as a Strategy for Developing a Medicine for Alzheimer's Disease
    José‐Carlos Fernández‐Morales, Juan-Alberto Arranz-Tagarro, Enrique Calvo‐Gallardo, Marcos Maroto, Juan Fernando Padín, Antonio G. Garcı́a · 2012 · ACS Chemical Neuroscience
  19. Ca2+ Influx through Store-operated Ca2+ Channels Reduces Alzheimer Disease β-Amyloid Peptide Secretion
    William Zeiger, Kulandaivelu S. Vetrivel, Virginie Buggia-Prévot, Phuong D. Nguyen, Steven L. Wagner, Mitchel L. Villereal, Gopal Thinakaran · 2013 · Journal of Biological Chemistry
  20. Carvedilol Reestablishes Long-Term Potentiation in a Mouse Model of Alzheimer's Disease
    Isabel Arrieta‐Cruz, Jun Wang, Constantine Pavlides · 2010 · Journal of Alzheimer s Disease
  21. Demonstration of safety in Alzheimer's patients for intervention with an anti‐hypertensive drug Nilvadipine: results from a 6‐week open label study
    Seán Kennelly, Laila I. Abdullah, Daniel Paris, J. Parish, Venkatarajan Subramanian Mathura, MICHAEL J. MULLAN, Fiona Crawford, BRIAN A. LAWLOR, Rose Anne Kenny · 2010 · International Journal of Geriatric Psychiatry
  22. The Novel Cognitive Enhancer ST101 Enhances Acetylcholine Release in Mouse Dorsal Hippocampus Through T-type Voltage-Gated Calcium Channel Stimulation
    Yui Yamamoto, Norifumi Shioda, Feng Han · 2013 · Journal of Pharmacological Sciences
  23. Presenilins regulate the cellular activity of ryanodine receptors differentially through isotype-specific N-terminal cysteines
    Andrew J. Payne, Bryan C. Gerdes, Yuliya Naumchuk, Audrey E. McCalley, Simon Kaja, Peter Koulen · 2013 · Experimental Neurology
  24. ST101 induces a novel 17kDa APP cleavage that precludes Aβ generation in vivo
    Kim N. Green, Hasan Khashwji, Tatiana Estrada, Frank M. LaFerla · 2011 · Annals of Neurology
  25. Why Migraines Strike
    David W. Dodick, J. Jay Gargus · 2008 · Scientific American
  26. Therapeutic Targeting of the Endoplasmic Reticulum in Alzheimers Disease
    Wayne Chadwick, Nicholas A. Mitchell, Bronwen Martin, Stuart R. Maudsley · 2012 · Current Alzheimer Research
  27. RECENT DEVELOPMENTS IN ALZHEIMER’S DISEASE
    Patrick P Cras · 2001 · Acta Clinica Belgica
  28. Calcium Enhances The Proteolytic Activity Of BACE: An In Vitro Biophysical And Biochemical Characterization Of The BACE-Calcium Interaction
    Michael Hayley, Samantha Perspicace, Therese Schulthess, Joachim Seelig · 2009 · Biophysical Journal
  29. Calcium Dyshomeostasis in β-Amyloid and Tau-bearing Skeletal Myotubes
    Rial A. Christensen, Alexander Shtifman, Paul Denney Allen, Jose Rafael Lopez, Henry W. Querfurth · 2004 · Journal of Biological Chemistry
  30. Mitochondria as the focus of apoptosis research
    Sten Orrenius, David H. Burgess, Mark B. Hampton, Boris Zhivotovsky · 1997 · Cell Death and Differentiation
  31. Involvement of presenilin holoprotein upregulation in calcium dyshomeostasis of Alzheimer's disease
    Kamran Honarnejad, Christian K. E. Jung, Sven Lammich, Thomas Arzberger, Hans A. Kretzschmar, Jochen Wolfgang Herms · 2013 · Journal of Cellular and Molecular Medicine
  32. Presynaptic roles of intracellular Ca2+ stores in signalling and exocytosis
    Sohaib Nizami, Vivian W.Y. Lee, Jennifer Davies, Philip Long, Jasmina N. Jovanovic, Talvinder S. Sihra · 2010 · Biochemical Society Transactions
  33. Alzheimer's Disease Pathology in Non-Demented Elderly
    Ann Marie Kazee, Eileen M. Johnson · 1998 · Journal of Alzheimer s Disease
  34. O1‐06–04: Methylthioninium chloride (MTC) acts as a Tau aggregation inhibitor (TAI) in a cellular model and reverses Tau pathology in transgenic mouse models of Alzheimer's disease
    Charles R. Harrington, Janet E. Rickard, David Horsley, Kathleen A. Harrington, Kathleen P. Hindley, Gernot Riedel, Franz Theuring, Kwang Meng Seng, Claude M. Wischik · 2008 · Alzheimer s & Dementia
  35. F1‐01‐04: Beta‐secretase as target for amyloid‐reduction therapy
    Jordan Tang · 2009 · Alzheimer s & Dementia
  36. PC‐05–03: Backed‐up against the wall: Pharmacology to assuage the PAADS (psychosis, apathy, agitation, depression, sleep problems) clusters in dementia
    Peter V. Rabins · 2013 · Alzheimer s & Dementia